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Acinetobacter-Derived Cephalosporinases (ADCs)

The rise of antibiotic resistance is a global health threat requiring
development of novel treatments. β-lactamase enzymes found in
many multi-drug resistant bacteria contribute to resistance of βlactam antibiotics. The enzyme cleaves the β-lactam ring, preventing
the drug from reaching its cellular target. A class of β-lactamases,
Acinetobacter-derived cephalosporinases (ADCs) are found in the
multi-drug resistant bacteria Acinetobacter baumannii. Specific
ADCs were selected from a group of antibiotic-resistant infections.
With no known structures of these newly identified ADCs, it is key to
discern how minor differences in sequences between ADCs
contribute to drug resistance. In this project, structural and kinetics
characterization of ADCs will aim to develop a relationship on how
small structural variations can affect the enzyme’s ability to bind and
destroy antibiotics. These results will help identify potential
inhibitors against enzymes that contribute to antibiotic resistance.
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A. baumannii contain class C β-lactamases called AcinetobacterDerived Cephalosporinases.
New ADCs have been isolated from recently infected individuals,
some of which have shown resistance to carbapenems.
These new variants have slightly different sequences that may be
responsible for structural changes in the enzyme, possibly
providing the ADC enzyme with an improved ability to bind and
inactivate antibiotics.
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Introduction
E. coli colonies plated on LBKanamycin

Process of β-lactam Antibiotic Function
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β-lactam antibiotics
work by binding to the
enzyme transpeptidase,
which is found in the
cell wall of the bacteria
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β-lactamases serve as one mechanism of bacteria that contribute
towards antibiotic resistance
β-lactamase enzymes bind and hydrolyze β-lactam antibiotics,
cleaving the β-lactam ring and making them inactive
The antibiotic is now unable to inhibit cell wall biosynthesis

• Crystals

are grown at varying concentrations
to determine if ADC variants crystallize in
the same known conditions as ADC-7

• Crystals

were grown to be used in X-ray
crystallography

Crystal tray for ADC-25

Crystallization: Hanging Drop Technique
• Crystallize protein using
hanging drop vapor
diffusion (0.1 M Succinate/
Phosphate/Glycine. pH 5.0)
• Crystals were soaked in a solution
containing drug/inhibitor amd
frozen using liquid N2

Example of a diffraction
pattern 3

NaCl is now
being added
(elution)

Time (min)

0.4

• After focused an X-ray beam hits the crystal, diffraction patterns
result from the electron density in the protein crystal.
• The diffraction patterns can be used to calculate a map of the
electron density of the protein (and allow for structure
determination).

Results
ADC-25 A200D/P220L/A
insert
ADC-30
ADC-33
ADC-162 (ADC-30 A221E)
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ADC-56
ADC-68
ADC-25 (ADC-30 T317N)
ADC-33 G223D
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Four of the variants have been purified through a one step CMcellulose method, resulting in about 50-80 mg of pure protein for each
of the following variants.
• ADC-25 (A200D/P220L/A insert)
• ADC-30
• ADC-33
• ADC-162 (ADC-30 A221E)
Numerous crystal trays were set up for all variants and were in
successful in growing crystals in three of them.
• ADC-30
• ADC-33
• ADC-162 (ADC-30 A221E)

Steady State Kinetics
HO

O
O

O

-

O

+

N

O

0.2

-

HO
S

N

0.1

+

S

NH

O

-

ADC-30

N

O

Nitrocefin
(yellow)

0.0

8

10

[ M B 0 7 6 ] , in  M

Competition kinetics were performed to determine the Ki values for
the ADC variants with MB076. This graph shows that MB076 binds
and prevents ADC-30 from inactivating nitrocefin. Assay conditions:
2 nM ADC-30, 10 mM NaPO4, pH 7.4, 60 μM NCF, variable
concentrations of MB076.
X-ray crystallography performed at Argonne National Laboratory
resulted in structures between 1.25 – 1.8 Å resolution. The following
six structures were obtained:
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The slight changes between the genetic sequences of ADC-7 and the
variants may have lead to changes in the ADC variant structure that
allows them to bind to a wider range of antibiotics. Thus, it is crucial to
characterize the structures that were obtained and determine what
structural differences exist between ADC-7 and the variants.
Identifying these differences is necessary as it ensure that potential
inhibitors are developed for enzymes that have been found in recently
infected individuals and will be applicable for treatment.

O

▪ Determine the crystal structures of the ADC variants and
investigate how these differences enable bacteria to be resistant to
more types of antibiotics.
▪ Complete kinetics to measure the Ki values for all ADC variants.
▪ Attempt to identify ideal crystal growing conditions for ADC-25
A200D/P220L/Ainsert crystals.
▪ The end goal of the project is to identify potential Boronic Acid
Transition State Inhibitors (BATSIs), such as MB076, that can be
used in tandem with β-lactam antibiotics to work against bacteria.
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NaCl from elution buffer was removed through dialysis (10 kDa
cutoff) and concentrated using an Amicon centrifugal filter unit.
Using UV-Vis spectrophotometry, the absorbance at 280 nm was
measured to allow for [ADC] quantitation for calculations needed
for crystal trays and steady state kinetics.
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UV-Vis spectrum from ADC-30 concentration
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Future Directions

Successful expression of plasmids for 8 ADC variants:

0.421 at 280 nm
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▪ ADC-30 apo and ADC-30 with MB076 bound
▪ ADC-33 apo and ADC-33 with MB076 bound
▪ ADC-162 apo and ADC-162 with MB076 bound

Argonne National Laboratory
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Elution profile of ADC purification by CM-cellulose chromatography
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Quantitation of ADC concentration

Antibiotic resistance is a growing concern and viewed as a global
health problem, necessitating the development of novel alternative
treatments to combat bacterial resistance towards antibiotics.
Antibiotic resistance occurs in the bacteria Acinetobacter
baumannii, which is an opportunistic bacterial pathogen. The
bacteria is labeled as a top priority by the World Health
Organization and the Centers for Disease Control. The bacteria
infects mainly at the hospital level in critical care and burn units,
particularly immunocompromised patients 1-2.
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P220L/Ains

1 L LB-Kanamycin cultures were grown and induced with IPTG
Cultures were centrifuged and resulting cell pellet was stored at
-80 oC.
Resuspended cell pellets (25 mM MOPS, pH 6.5) were sonicated,
centrifuged, and the supernatant was loaded on a carboxymethyl
(CM)-cellulose column at 4 oC.
The column was washed with 25 mM MOPS, pH 6.5 and eluted
with 25 mM MOPS, pH 6.5, 500 mM NaCl, leading to fractions
containing the purified ADC protein.
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Conclusions and Future Directions
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Growth and Purification With Ion Exchange
Chromatography
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Confirm protein
expression by gel
electrophoresis
(SDS-PAGE),
molecular weight
(MW) of ADC
protein is ~ 40 kDa

Transpeptidase (Penicillin Binding
Protein)

β-lactamase Enzymes and β-lactam Resistance
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A plasmid containing various ADC genes
were inserted into a non-pathogenetic
strain of E. coli.
From these resulting colonies, protein
expression was tested with non-induced
and induced conditions.

Crystal Tray Preparation
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The reaction rate was determined
for ADC inactivating a specific
cephalosporin antibiotic,
nitrocefin (NCF). Assay
conditions: 2 nM ADC-30, 10 mM
NaPO4, pH 7.4, variable
concentrations of NCF.
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